In this issue

Human Vaccines
Volume 6, Issue 2
February 2010
View current issue
About the cover
Tomogram of a single Human Papillomavirus-16 L1 virus-like particle (HPV-16 L1 VLP) obtained from cryo-electron microscopy imaging and processed using...
Continue reading




Meetings of Interest

World Vaccine Congress Lyon

October 5-8
Lyon, France


HINARI

Landes Bioscience gladly participates in the World Health Organizations' Access to Research Initiative (HINARI) to provide free online access to all papers published in Human Vaccines to scientists in developing countries worldwide.

Read more about the HINARI initiative.

Editor-in-Chief

Ronald W. Ellis
Senior Vice President
Chief Technology Officer
NasVax Ltd., Ness Ziona, Israel

Email the Managing Editor.

Print ISSN: 1554-8600
Online ISSN: 1554-8619 DOI: 10.4161/hv

What's New in 2010?

January Issue (6-1)
Special Issue on Malaria Vaccine Development! Dr. Denise Doolan from the Queensland Institute of Medical Research (Brisbane, QL, Australia) has kindly served as Guest Editor for this Special Issue, which is entirely devoted to malaria. She has recruited some of the world’s leading scientists in the malaria field and has put together a comprehensive collection of Reviews covering current approaches to and opinions on malaria vaccine development.


What's New in 2009?

December Issue (5-12)

The last issue for 2009 will have a new feature: the initial News & Policy section published in Human Vaccines! This novel section will cover the latest developments in the world of vaccines in all segments from research to clinical to public health, academia and government, biotech and industry, and in addition report on relevant events and awards. This new section will continue throughout the coming year and beyond.

We will accept pieces for News and Policy on shorter notice than for our regular articles in order that this section can be published to be as current as possible. If you would like to contribute an opinion piece relevant to the field of human vaccines or if your company/organization has any important news to share now or in the future, please directly contact Eva Riedmann and/or provide us with your press-release.

Furthermore, we would like to draw your attention to our Special Focus on Vaccines for Biodefense. This Special Focus features reviews on five category A bioterrorism agents: Anthrax, Botulism, Plague, Smallpox and Tularemia.


Submit your paper to Human Vaccines

Human Vaccines utilizes an online submission and tracking system designed to provide efficient service to authors. Through the online system, author files are automatically converted to PDFs, submissions are acknowledged by email, and authors can track their manuscript through the stages of the peer review process.

Click here to submit your manuscript to Human Vaccines.

Human Vaccines is indexed in Medline/PubMed and in the Science Citation Index Expanded.


Faculty Position in Vaccine Epidemiology

Dalhousie University is inviting applications to fill a full-time, initial five-year term faculty position in the Department of Pediatrics, Faculty of Medicine and the newly established Canadian Centre for Vaccinology (CCfV). The position is at the level of Assistant Professor.

For more information please visit the website or download the attached PDF.


Advertisements